Status:
COMPLETED
Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Anxiety
Insomnia
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The main purpose of this 12-week study is to see if a new combination of treatments can help older adults reduce benzodiazepine or related medication use. The treatment combination consists of 1) medi...
Detailed Description
This study consists of a single-arm clinical study among 30 older adults taking benzodiazepine receptor antagonists (BRZA) to assess the feasibility of protocol-driven BRZA deprescribing augmented wit...
Eligibility Criteria
Inclusion
- 65 years and older
- Taking benzodiazepines or related medications (i.e. zolpidem, zopiclone, eszopiclone, zaleplon) at least 4 times in the last month
- English speaking
- Ability to understand study procedures and to comply with them for the length of the study
Exclusion
- Cognitive impairment
- Drinking more than 3 alcoholic beverages per day
- Substance abuse disorder
- Uncontrolled psychiatric disorder, such as major depression or psychosis
- Inability or unwillingness of individual or legal guardian.representative to give written informed consent.
Key Trial Info
Start Date :
December 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2025
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT06197243
Start Date
December 14 2023
End Date
May 23 2025
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osher Center for Integrative Health at Vanderbilt
Nashville, Tennessee, United States, 37203